Clinical Trial Update: A Bridging Trial Comparing Sugammadex (Org 25969) at Reappearance of T2 in Japanese and Caucasian Participants. Part B: Caucasian Participants (P05971) [Phase 2]

View source ↗

Summary

Phase 2 bridging trial comparing Sugammadex (Org 25969) reappearance of T2 in Caucasian participants; results completed with posted results in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anesthesia-related Perioperative Care

Drugs mentioned

• Sugammadex (sugammadex)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Anesthesia, General | Phase 2 | Status: COMPLETED | Results posted: 2019-02-15